Advanced, FDA-approved treatment for depression when other options haven’t worked.
Many individuals in Worcester come to us after trying multiple antidepressants without finding lasting relief.
Spravato offers a different approach — targeting alternative brain pathways and potentially providing faster symptom improvement for some patients.
This treatment is carefully administered in a monitored clinical setting to ensure safety, comfort, and effectiveness.
Spravato is an FDA-approved nasal spray treatment derived from esketamine, used for individuals with treatment-resistant depression. It is administered in a controlled clinical setting under medical supervision.
For treatment-resistant depression.
Derived from ketamine.
Administered under supervision.
Targets unique brain pathways.
Scheduled sessions with monitoring.
Provided in certified settings.
We carefully evaluate each patient to determine if Spravato is the right fit based on clinical history and individual needs.
Spravato may offer a new path forward when other treatments haven’t worked.
Choosing the right provider matters. Here’s what sets us apart.
Culturally competent, personalized support tailored to you.
Deep understanding of Worcester community needs.
Focused experience in depression and mental health care.
Convenient telehealth scheduling across Massachusetts.
HIPAA-compliant, secure, and private treatment.
Yes, administered in certified settings.
Works on different brain pathways.
No, it is supervised in-office.
Often covered when criteria are met.